Best Healthcare Stocks by ST Score
Top 30 results, ranked from our full US coverage.
This screen ranks every healthcare company we cover by its ST Score — a single 0–100 rating that blends valuation, growth, profitability, financial strength and momentum into one number.
Because grades are set against sector peers, the names at the top are the ones scoring well relative to other healthcare businesses rather than against the market as a whole.
Use it as a starting shortlist: open any symbol to see the full factor breakdown, analyst consensus and recent price action before you act.
| # | Symbol | Company | Sector | Price | Market cap | Grade | Analysts | ST Score |
|---|---|---|---|---|---|---|---|---|
| 1 | ODTX | Odyssey Therapeutics, Inc. | Healthcare | $24.38 | $1.17B | B+ | Buy | 74.7 |
| 2 | SPTX | Seaport Therapeutics, Inc. Common Stock | Healthcare | $21.39 | $1.15B | B+ | Buy | 73.5 |
| 3 | TCMD | Tactile Systems Technology, Inc. | Healthcare | $22.20 | $500.7M | B+ | Buy | 73.4 |
| 4 | INSP | Inspire Medical Systems, Inc. | Healthcare | $76.78 | $2.22B | B+ | Hold | 73.0 |
| 5 | COAG | Hemab Therapeutics Holdings, Inc. Common Stock | Healthcare | $37.97 | $1.77B | B+ | Buy | 72.4 |
| 6 | BLSM | BlossomHill Therapeutics, Inc. | Healthcare | $26.80 | $779.4M | B+ | — | 71.8 |
| 7 | FENC | Fennec Pharmaceuticals Inc. | Healthcare | $10.62 | $368.9M | B+ | Buy | 70.9 |
| 8 | OSCR | Oscar Health, Inc. | Healthcare | $32.13 | $8.33B | B+ | Hold | 70.7 |
| 9 | ABUS | Arbutus Biopharma Corp | Healthcare | $5.00 | $987.7M | B+ | Buy | 69.5 |
| 10 | NUTX | Nutex Health, Inc. | Healthcare | $208.79 | $1.44B | B+ | Buy | 69.5 |
| 11 | DCTH | Delcath Systems, Inc. | Healthcare | $16.11 | $556.1M | B+ | Buy | 69.4 |
| 12 | ELOX | Eloxx Pharmaceuticals, Inc. | Healthcare | $17.19 | $59.1M | B+ | Buy | 69.3 |
| 13 | IFRX | InflaRx N.V. | Healthcare | $2.09 | $307.8M | B+ | Buy | 69.2 |
| 14 | KMDA | Kamada Ltd. | Healthcare | $8.85 | $510.6M | B+ | Buy | 68.7 |
| 15 | SIBN | SI-BONE, Inc. | Healthcare | $18.09 | $802.3M | B+ | Buy | 68.6 |
| 16 | ELV | Elevance Health Inc. | Healthcare | $409.31 | $88.77B | B+ | Buy | 68.4 |
| 17 | GMED | Globus Medical, Inc. | Healthcare | $74.08 | $9.99B | B+ | Buy | 68.3 |
| 18 | ANIK | Anika Therapeutics, Inc. | Healthcare | $20.70 | $277.0M | B+ | Buy | 68.2 |
| 19 | CDNA | CareDx, Inc | Healthcare | $54.33 | $2.81B | B+ | Buy | 68.2 |
| 20 | HCSG | Healthcare Services Group, Inc. | Healthcare | $21.47 | $1.47B | B+ | Hold | 68.1 |
| 21 | ANL | Adlai Nortye Ltd. | Healthcare | $15.57 | $826.5M | B | Buy | 67.9 |
| 22 | CAH | Cardinal Health, Inc. | Healthcare | $225.75 | $52.87B | B | Buy | 67.9 |
| 23 | JNJ | Johnson & Johnson | Healthcare | $269.99 | $650.65B | B | Buy | 67.9 |
| 24 | EW | Edwards Lifesciences Corporation | Healthcare | $88.26 | $50.82B | B | Buy | 67.7 |
| 25 | WST | West Pharmaceutical Services, Inc. | Healthcare | $362.16 | $25.49B | B | Buy | 67.7 |
| 26 | ELVN | Enliven Therapeutics, Inc. | Healthcare | $48.87 | $3.49B | B | Buy | 67.5 |
| 27 | ARGX | argenx SE | Healthcare | $988.20 | $61.45B | B | Buy | 67.4 |
| 28 | AVLN | Avalyn Pharma Inc. Common Stock | Healthcare | $31.62 | $1.40B | B | Buy | 67.2 |
| 29 | MDXG | MiMedx Group, Inc. | Healthcare | $4.77 | $695.3M | B | Buy | 67.2 |
| 30 | IRD | Opus Genetics, Inc. | Healthcare | $5.18 | $427.7M | B | Buy | 66.9 |
Want to change the thresholds? Open the full stock screener and adjust any of the 100+ filters.
Frequently asked questions
What are the best healthcare stocks right now?
The table above lists the healthcare stocks with the highest ST Scores today. A higher score means the company grades well across valuation, growth, profitability, financial strength and momentum at the same time.
How is the ST Score calculated for healthcare companies?
Each factor is graded A+ to F against sector peers, then the grades are combined into a 0–100 ST Score. Full detail is on our ST Score methodology page.
How often is this healthcare list updated?
Grades, scores and fundamentals refresh with each data run, so the ranking changes as new financials, prices and analyst estimates arrive.
Is a high ST Score a recommendation to buy?
No. The ST Score is a data-driven summary of a company's current profile, not investment advice. Treat this list as a research shortlist and do your own analysis.
Popular screens
Ready-made lists built from the same data — no filters to set.